ExpreS2ion Biotech Holding AB - ESG Rating & Company Profile powered by AI
The ESG rating covers 17 United Nations SDGs including: 'Good Health & Wellbeing', 'Climate Action' and 'Partnerships for the Goals'. If you work at ExpreS2ion Biotech Holding AB and you would like to licence your Sustainability aseessment, please get in touch. Browse to the end of this webpage for potential risks for ExpreS2ion Biotech Holding AB based on sector, location and size.
ExpreS2ion Biotech Holding AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 2.7, social score of 8.0 and governance score of 4.0.
4.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
744 | Sopharma AD | 5.0 | High |
744 | vTv Therapeutics Inc | 5.0 | High |
764 | ExpreS2ion Biotech Holding AB | 4.9 | High |
764 | BetterLife Pharma Inc | 4.9 | High |
764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does ExpreS2ion Biotech Holding AB have an accelerator or VC vehicle to help deliver innovation?
Does ExpreS2ion Biotech Holding AB disclose current and historical energy intensity?
Does ExpreS2ion Biotech Holding AB report the average age of the workforce?
Does ExpreS2ion Biotech Holding AB reference operational or capital allocation in relation to climate change?
Does ExpreS2ion Biotech Holding AB disclose its ethnicity pay gap?
Does ExpreS2ion Biotech Holding AB disclose cybersecurity risks?
Does ExpreS2ion Biotech Holding AB offer flexible work?
Does ExpreS2ion Biotech Holding AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does ExpreS2ion Biotech Holding AB disclose the number of employees in R&D functions?
Does ExpreS2ion Biotech Holding AB conduct supply chain audits?
Does ExpreS2ion Biotech Holding AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does ExpreS2ion Biotech Holding AB conduct 360 degree staff reviews?
Does ExpreS2ion Biotech Holding AB disclose the individual responsible for D&I?
Does ExpreS2ion Biotech Holding AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does ExpreS2ion Biotech Holding AB disclose current and / or historical scope 2 emissions?
Does ExpreS2ion Biotech Holding AB disclose water use targets?
Does ExpreS2ion Biotech Holding AB have careers partnerships with academic institutions?
Did ExpreS2ion Biotech Holding AB have a product recall in the last two years?
Does ExpreS2ion Biotech Holding AB disclose incidents of discrimination?
Does ExpreS2ion Biotech Holding AB allow for Work Councils/Collective Agreements to be formed?
Has ExpreS2ion Biotech Holding AB issued a profit warning in the past 24 months?
Does ExpreS2ion Biotech Holding AB disclose parental leave metrics?
Does ExpreS2ion Biotech Holding AB disclose climate scenario or pathway analysis?
Does ExpreS2ion Biotech Holding AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does ExpreS2ion Biotech Holding AB disclose the pay ratio of women to men?
Does ExpreS2ion Biotech Holding AB support suppliers with sustainability related research and development?
Does ExpreS2ion Biotech Holding AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does ExpreS2ion Biotech Holding AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is ExpreS2ion Biotech Holding AB involved in embryonic stem cell research?
Does ExpreS2ion Biotech Holding AB disclose GHG and Air Emissions intensity?
Does ExpreS2ion Biotech Holding AB disclose its waste policy?
Does ExpreS2ion Biotech Holding AB report according to TCFD requirements?
Does ExpreS2ion Biotech Holding AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does ExpreS2ion Biotech Holding AB disclose energy use targets?
Does ExpreS2ion Biotech Holding AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does ExpreS2ion Biotech Holding AB have a policy relating to cyber security?
Have a different question?
Potential Risks for ExpreS2ion Biotech Holding AB
These potential risks are based on the size, segment and geographies of the company.
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.